JUL 17, 2018 01:35 PM PDT

First Drug for Smallpox Treatment

WRITTEN BY: Nouran Amin
2 1 133

TPOXX (tecovirimat), the first drug with an indication for treatment of smallpox, was just approved by the U.S. Food and Drug Administration to SIGA Technologies Inc. The development of TPOXX was in conjunction with the U.S. Department of Health and Human Services’ Biomedical Advanced Research and Development Authority (BARDA).

Even though eradicated in 1980, the World Health Organization (WHO) announced that smallpox as a contagious and sometimes fatal infectious disease that can be used as a bioweapon.

“To address the risk of bioterrorism, Congress has taken steps to enable the development and approval of countermeasures to thwart pathogens that could be employed as weapons. Today’s approval provides an important milestone in these efforts. This new treatment affords us an additional option should smallpox ever be used as a bioweapon,” said FDA Commissioner Scott Gottlieb, M.D. "This is the first product to be awarded a Material Threat Medical Countermeasure priority review voucher. Today’s action reflects the FDA’s commitment to ensuring that the U.S. is prepared for any public health emergency with timely, safe and effective medical products.”

Before its 1980 eradication, variola virus, the virus that leads to smallpox, it was mainly spread by direct contact between people. The symptoms typically began 10 to 14 days after infection and include fever, exhaustion, headache, and backache followed by a rash initially with small, pink bumps progressed to pus-filled sores before finally crusting over and scarring. Smallpox complications include encephalitis (inflammation of the brain), corneal ulcerations (an open sore on the clear, front surface of the eye) and blindness.

The efficacy of TPOXX against smallpox was concluded by studies on animals infected with viruses that are closely related to the virus that results in smallpox and was based on measuring survival at the end of the studies. The studies showed that the animals treated with TPOXX have survived compared to the animals treated with a placebo.

Using the FDA’s Animal Rule, which ensures efficacy are adequate from well-controlled animal research findings, TPOXX was approved.

TPOXX safety was evaluated using clinical trials on 359 healthy human volunteers without a smallpox infection and the most frequently reported side effects included a headache, nausea, and abdominal pain. Additionally, TPOXX received the Orphan Drug designation, which allows incentives to assist and inspire the development of drugs for rare diseases and a Material Threat Medical Countermeasure Priority Review Voucher, which provides additional incentives for specific medical products intended to treat or prevent harm from specific chemical, biological, radiological and nuclear threats.

 

About the Author
  • Nouran enjoys writing on various topics including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
APR 10, 2018
Drug Discovery
APR 10, 2018
Inhibiting a Receptor Protein to Treat a Rare Form of Uterine Cancer
Uterine serous carcinoma is rare occurring in less than 10 percent of all cancer types of the endometrium. However, this particular uterine cancer is respo
JUN 06, 2018
Drug Discovery
JUN 06, 2018
Gas Embolotherapy: Potential New Drug Delivery System
The use of various techniques to cut off the blood vessels that feed tissue growth is known as embolization. Embolization has acquired attention from the p
JUN 27, 2018
Infographics
JUN 27, 2018
The Role of Biomarkers In Modern Medicine
A biomarker (short for biological marker) is a measurable indicator of some biological state or condition. The biomarker can be measured objectively and consistently. Biomarkers play signific
JUL 04, 2018
Drug Discovery
JUL 04, 2018
First Drug Approved for The Treatment of Hyperhidrosis
Hyperhidrosis is a chronic skin condition that results in the increased production of sweat than needed. A certain amount of sweat is normally produced to
JUL 17, 2018
Drug Discovery
JUL 17, 2018
Hunger Hormones for Addiction Treatment?
Hunger hormones, or gut hormones, work to signal the body's state of hunger and fullness. These hormones could potentially serve as a key new treatment
AUG 15, 2018
Drug Discovery
AUG 15, 2018
Peripheral Nerve Blockers Treat Facial Pain
A new research study published American Journal of Emergency Medicine explains the use of peripheral nerve inhibitors in the treatment of facial pain condi
Loading Comments...